PUBLISHER: Verified Market Research | PRODUCT CODE: 1630081
PUBLISHER: Verified Market Research | PRODUCT CODE: 1630081
Increasing demand for non-invasive diagnostic tools has been projected to drive the growth of the bladder scanner market, as these devices are anticipated to improve patient comfort and reduce healthcare costs. According to the analyst from Verified Market Research, the Bladder Scanner Market is estimated to reach a valuation of USD 229.44 Million over the forecast subjugating around USD 154.5 Million valued in 2024.
The rapid expansion of the bladder scanner market is primarily driven by the growing prevalence of urological disorders, which is expected to increase the need for early diagnosis and treatment, thereby contributing to a higher CAGR. It enables the market to grow at a CAGR of 5.59% from 2024 to 2031.
Bladder Scanner Market: Definition/ Overview
A bladder scanner is a non-invasive medical device used to assess bladder volume and detect urinary retention by producing ultrasound images of the bladder. These scanners are primarily utilized in clinical settings to help diagnose and monitor urological conditions such as urinary incontinence, bladder dysfunction, and post-operative complications. By providing accurate and immediate measurements, bladder scanners have been adopted in hospitals, clinics, and nursing homes to improve patient care and reduce the need for unnecessary catheterization.
Increasing demand for non-invasive diagnostic tools has contributed significantly to the market's growth, driven by the rising incidence of urological disorders and the growing elderly population. Additionally, the adoption of bladder scanners has been fueled by advancements in ultrasound technology, which have enhanced the accuracy and efficiency of these devices. The market is expected to expand as healthcare providers seek cost-effective and patient-friendly solutions for managing bladder health.
Increasing prevalence of urological disorders is contributing to the rising demand for bladder scanners in the global healthcare market. Urological disorders, including urinary tract infections (UTIs), urolithiasis, and benign prostatic hyperplasia (BPH), represent significant health challenges globally. According to the Global Burden of Disease Study 2019, the prevalence of these conditions has increased markedly over the past few decades. Specifically, incident cases of UTIs rose by 60.4%, urolithiasis by 48.57%, and BPH by 105.7% from 1990 to 2019.
Bladder scanner devices offer real-time visualization and accurate measurements of bladder volume, which reduce the risk of urinary retention and associated complications. Furthermore, the adoption of bladder scanners is expected to increase due to the growing focus on improving patient safety and comfort, especially in geriatric care. The cost-effectiveness of bladder scanners in reducing catheter-associated urinary tract infections (CAUTI) has also been projected to drive market growth.
The high cost of advanced bladder scanning devices is a key restraint limiting the growth of the bladder scanner market. Many healthcare facilities, especially in developing and underdeveloped regions, face budgetary constraints that limit their ability to adopt these technologies.
Advanced bladder scanners, which offer real-time imaging and improved accuracy, are often associated with significant upfront investments and ongoing maintenance costs. These financial limitations have been projected to restrict the adoption of bladder scanners in smaller hospitals and clinics, particularly in regions with limited healthcare funding.
Additionally, the lack of skilled professionals to operate bladder scanners has been identified as another challenge that impacts the overall market growth. It is anticipated that without addressing these barriers, the global penetration of bladder scanners may remain limited, especially in low-income areas where healthcare budgets are constrained. Despite the growing need for diagnostic tools, these cost-related barriers have been expected to hinder widespread market adoption.
According to VMR analyst, the dominance of portable bladder scanners in the bladder scanner market has been primarily attributed to their ease of use, mobility, and advanced technological features. Portable bladder scanners are designed to be compact and lightweight, allowing for greater flexibility in diagnostic settings such as hospitals, clinics, and even home care environments.
The increasing preference for point-of-care diagnostics has been projected to drive the demand for portable bladder scanners, particularly in emergency and critical care situations where quick and accurate assessments are necessary. These devices have been anticipated to offer real-time imaging and non-invasive measurements, reducing the need for catheterization and lowering the risk of infections. In addition, the rising incidence of urological conditions and the growing geriatric population have been expected to fuel the adoption of portable scanners.
According to VMR Analyst, the rapid growth of urology applications in the bladder scanner market has been driven by the increasing prevalence of urological disorders and the growing demand for early diagnosis and treatment. Urology applications have been projected to account for a significant share of the market due to the rising incidence of urinary incontinence, bladder dysfunction, and benign prostatic hyperplasia (BPH).
The aging population has been expected to further exacerbate these conditions, leading to a higher demand for diagnostic tools like bladder scanners. The non-invasive nature of these devices, combined with their ability to provide accurate bladder volume measurements, has been anticipated to enhance their adoption in urology practices. Additionally, the reduction in catheter-associated infections through the use of bladder scanners has been considered a crucial factor promoting their use in urology.
According to VMR Analyst, North America's dominance in the bladder scanner market has been attributed to several key factors, including advanced healthcare infrastructure, the growing prevalence of urological conditions, and increasing adoption of non-invasive diagnostic technologies. The high incidence of urinary incontinence and bladder-related disorders, particularly among the aging population, has been anticipated to drive the demand for bladder scanners across hospitals and clinics in the region.
Additionally, technological advancements in medical devices and the presence of key market players have been projected to further enhance the availability and use of bladder scanners. Government initiatives aimed at improving healthcare access and reducing hospital-acquired infections, such as catheter-associated urinary tract infections (CAUTI), have also been expected to support market growth. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending grew 9.7% in 2020, reaching $4.1 trillion or $12,530 per person. This high healthcare expenditure facilitates the adoption of advanced medical devices like bladder scanners.
The rapid growth of Asia Pacific region has been significantly shaped by government initiatives focused on improving healthcare infrastructure and expanding access to advanced diagnostic technologies. Emerging economies such as China and India have been anticipated to experience rapid growth due to increased healthcare spending and rising awareness of urological conditions.
The growing geriatric population in the region has further driven the demand for non-invasive bladder diagnostics, as bladder scanners have been projected to play a crucial role in managing age-related urinary disorders. According to the UNESCAP report "Ageing in Asia and the Pacific: Overview", in 2016 approximately 12.4% of the population in the region was 60 years or older, which is projected to increase to more than a quarter (1.3 billion) by 2050. Additionally, healthcare reforms aimed at reducing catheter-associated urinary tract infections (CAUTI) have been expected to increase the adoption of bladder scanners across hospitals and clinics.
The Bladder Scanner Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.
Some of the prominent players operating in the bladder scanner market include:
GE Healthcare, Inc.
Roper Technologies, Inc.
Mcube Technology Co. Ltd
Vitacon
dBMEDx, Inc.
SonoScape Medical Corporation
Fukuda Denshi Co., Ltd.
US Medical
Edan Instruments, Inc.
Meditech Holdings Plc
Terasona
Sonosite, Inc.
Esaote SpA
Mindray Medical International Limited
Meditech Systems Corporation
SonoSite, Inc.
In January 2024, SonoSite announced that its iPX ultrasound system, which includes a specialized app for bladder volume assessment, has received FDA certification. This software attempts to improve the accuracy and efficiency of non-invasive bladder volume measurements.
In January 2024, EchoNous collaborated with Medtronic to incorporate bladder volume evaluation into their surgical navigation system. This cooperation intends to improve urological operations by utilizing real-time bladder capacity data.
In December 2023, Fukuda Denshi displayed the US-F800 bladder scanner, which incorporates AI-powered automatic bladder recognition and measurement for faster and more accurate scans.
In November 2023, dBMEDx's DB100 scanner received CE Mark clearance, expanding its reach into the European market. This portable scanner provides an affordable solution for measuring bladder volume.
In October 2023, Mcube collaborated with Medtronic to integrate its bladder scanner technology into Medtronic's patient monitoring systems, with the goal of improving remote bladder management for patients with chronic urine problems.